Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:3097-3101
Published online before print December 15, 2003, doi: 10.1161/01.CIR.0000103123.66264.FE
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/25/3097    most recent
01.CIR.0000103123.66264.FEv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huggett, R. J.
Right arrow Articles by Mary, D. A.S.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggett, R. J.
Right arrow Articles by Mary, D. A.S.G.
Related Collections
Right arrow Other hypertension
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Type 2 diabetes

(Circulation. 2003;108:3097-3101.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension

Robert J. Huggett, MB, BS; Eleanor M. Scott, BM, BS, MD; Stephen G. Gilbey, BA, MD; John B. Stoker, BSc, MB, ChB; Alan F. Mackintosh, MA, MD; David A.S.G. Mary, MB, ChB, PhD

From the Department of Cardiology (R.J.H., J.B.S., A.F.M., D.A.S.G.M.) and Diabetes & Endocrinology (E.M.S., S.G.G.), St James’s University Hospital, Leeds, United Kingdom.

Correspondence to Dr R.J. Huggett, Department of Cardiology, St James’s University Hospital, Beckett St, Leeds LS9 7TF, United Kingdom. E-mail roberthuggett{at}hotmail.com

Received April 3, 2003; de novo received July 18, 2003; revision received September 19, 2003; accepted September 22, 2003.

Background— Essential hypertension (EHT) is a major cardiovascular risk factor, and the additional presence of type 2 diabetes mellitus (DM2) increases this risk. However, although the sympathetic nerve hyperactivity of EHT is known to play a role in cardiovascular risk, the level of sympathetic nerve activity is known neither in DM2 nor in hypertensive type 2 diabetic patients (EHT+DM2). Therefore, we planned to quantify the vasoconstrictor sympathetic nerve activity in patients with EHT+DM2 and with DM2 relative to that in matched groups with EHT and normal blood pressure (NT).

Methods and Results— In 68 closely matched subjects with EHT+DM2 (n=17), DM2 (n=17), EHT (n=17), and NT (n=17), we measured resting muscle sympathetic nerve activity as the mean frequency of multiunit bursts (MSNA) and of single units (s-MSNA) with defined vasoconstrictor properties. The s-MSNA in EHT+DM2 (97±3.8 impulses/100 beats) was greater (at least P<0.001) than in EHT (69±3.4 impulses/100 beats) and DM2 (78±4.1 impulses/100 beats), and all these were significantly greater (at least P<0.01) than in NT (53±3.3 impulses/100 beats) despite similar age and body mass index. The MSNA followed a similar trend. In addition, the level of insulin was also raised in EHT+DM2 (20.4±3.6 µU/mL) and DM2 (18.1±3.1 µU/mL; at least P<0.05) compared with HT or NT.

Conclusions— Patients with EHT+DM2, EHT, or DM2 had central sympathetic hyperactivity, although plasma insulin levels were raised only in EHT+DM2 and DM2. The combination of EHT and DM2 resulted in the greatest sympathetic hyperactivity and level of plasma insulin, and this hyperactivity could constitute a mechanism for the increased risks of this condition.


Key Words: nervous system, sympathetic • hypertension • diabetes mellitus




This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. Ao, N. Toy, M. K. Song, V. L. W. Go, and H. Yang
Altered Glucose and Insulin Responses to Brain Medullary Thyrotropin-Releasing Hormone (TRH)-Induced Autonomic Activation in Type 2 Diabetic Goto-Kakizaki Rats
Endocrinology, December 1, 2005; 146(12): 5425 - 5432.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. J. Huggett, J. Burns, A. F. Mackintosh, and D. A.S.G. Mary
Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension
Hypertension, December 1, 2004; 44(6): 847 - 852.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Bitz, S. Toubro, T. M. Larsen, H. Harder, K. L. Rennie, S. A. Jebb, and A. Astrup
Increased 24-h Energy Expenditure in Type 2 Diabetes
Diabetes Care, October 1, 2004; 27(10): 2416 - 2421.
[Abstract] [Full Text] [PDF]